Institutional Ownership

CARGO THERAPEUTICS (CRGX) Institutional Ownership & Top Holders

The most recent SEC Form 13F filings (Q2 2025) show 4 hedge funds and institutional investors holding a combined 9.8M shares of CARGO THERAPEUTICS (CRGX), valued at $40.6M. The median portfolio weight is 0.6%.

The latest institutional ownership changes for CRGX show net buying, with the combined position up by 1.2M shares (13.6%) from the previous quarter.

Among 13F filers, the funds with the highest portfolio allocation to CRGX are SAMSARA BIOCAPITAL (3.7% of its 13F portfolio), Madison Avenue Partners (1.2%), and RTW Investments (0.1%). In Q2 2025, Madison Avenue Partners made the largest position increase (+1.1%), while RTW Investments made the largest reduction (-0.2%).

Top 4 Institutional Holders in CARGO THERAPEUTICS (CRGX), Ranked by Portfolio Weight

Based on the latest SEC Form 13F filings (Q2 2025).

# Fund Shares Market Value Portfolio Weight
1 SAMSARA BIOCAPITAL 4,415,689 $18.2M 3.7%
2 Madison Avenue Partners 4,193,626 $17.3M 1.2%
3 RTW Investments 1,212,562 $5.0M 0.1%
4 Stanford University 23,273 $96K 0.0%
Latest
  • 4
    Institutional investors
  • 9,845,150
    Shares held (disclosed)
  • $40.6M
    13F market value
  • 0.6%
    Median portfolio weight

Ownership History

Quarter-by-quarter share count, market value, and portfolio conviction weight (up to 5 of the heaviest weight-by-portfolio funds) of CRGX. Sourced from 13F filings; reflects long equity positions only.

Quarter-over-Quarter ActivityQ2 2025

The biggest weight-increase and weight-decrease changes among funds that hold CRGX. Deltas compare the selected filing to the previous reporting quarter.

Top buyers

Top sellers

Ownership Statistics

Funds holding
4
Median weight
0.6%
Largest holder
SAMSARA BIOCAPITAL · 3.7%
Smallest holder
Stanford University · 0.0%
Shares held
9,845,150 (+1,180,377)

All Institutional HoldersSortable · searchable

All institutional investors (Max 50) holding CRGX in the selected quarter. Click a fund name to drill into its full 13F portfolio.

4 of 4 institutional investors
1SAMSARA BIOCAPITAL4,415,689$18.2M3.7%
2Madison Avenue Partners4,193,626$17.3M1.2%
3RTW Investments1,212,562$5.0M0.1%
4Stanford University23,273$95.9K0.0%

Institutional Investor Count Over Time

Number of institutional investors disclosing a long position in CARGO THERAPEUTICS INC (CRGX) each reporting quarter. Sourced from SEC Form 13F-HR filings.

Methodology & FAQ

Methodology: How We Track CRGX Institutional Holdings

Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).

  • Who Must File (Reporting Threshold): This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in Section 13(f) securities (including equities, options, convertibles, ETFs, and warrants).
  • What is Included (Data Scope): We capture long positions in Section 13(f) securities for CARGO THERAPEUTICS INC (CRGX). By SEC regulation, 13F filings do not require the disclosure of short positions, non-U.S. holdings, or OTC derivatives. Listed options are excluded from portfolio weight calculations to ensure comparability across filers.
  • Portfolio Weight Explained (Metric Definition): “Portfolio Weight” shows how much of a fund's total reported 13F portfolio value (excluding listed options) is allocated to CRGX on the specific reporting date.
  • How to Use This Data (Interpretation): Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
How do you measure hedge fund conviction and institutional concentration in CRGX?

We evaluate fund conviction by looking at portfolio weight rather than just absolute share count. By tracking how the largest holders —such as SAMSARA BIOCAPITAL , Madison Avenue Partners , and RTW Investments as of Q2 2025 change their position sizing quarter-over-quarter, we help investors distinguish between deliberate position sizing changes and passive mark-to-market drift.

Does the CRGX ownership data include short interest or options?

SEC Form 13F mandates the disclosure of long positions in Section 13(f) securities, which includes equities and listed options (put and call contracts), but excludes short interest, swaps, and OTC derivatives by regulatory design. On this platform, listed options are excluded from portfolio weight calculations to ensure comparability across filers.

Are family offices and university endowments included in this CRGX data?

Yes. In addition to traditional hedge funds and large asset managers, any institutional entity exercising investment discretion over at least $100 million in Section 13(f) securities must file a Form 13F. This explicitly includes single-family offices and university endowments. If a qualifying family office or endowment holds CRGX stock, their allocation is systematically aggregated alongside traditional fund data.

When is the institutional ownership data updated, and is there a reporting lag?

Institutional investment managers are required to file their Form 13F within 45 days after the end of a calendar quarter (the standard “T+45” window). Our platform re-ingests new filings from the SEC EDGAR database on a nightly cycle, typically within 24–48 hours of publication, providing a point-in-time snapshot of reported consensus positioning for CRGX as of each filing date.